상세 보기
Cancer Investigation
ISSN
P 0735-7907 E 1532-4192
출판사
Marcel Dekker Inc.
국가
USA
발행 상태
활성
데이터베이스 수록 정보
EMBASE 2016-2020 (5년)
JCR 1997-2019 (23년)
MEDLINE 2016-2021 (6년)
SCI 2010-2019 (10년)
SCIE 2010-2021 (12년)
Scopus 2017-2020 (4년)
SJR 1999-2019 (21년)
전체 4건 중 1번부터 4번까지의 결과를 표시합니다.
2026
Article
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer (ABC): A Subgroup Analysis in CDK4/6 inhibitor (CDK4/6i)-pretreated patients from EMBER-3
- Saura, Cristina ;
- Carey, Lisa ;
- Curigliano, Giuseppe ;
- Harbeck, Nadia ;
- O'shaughnessy, Joyce ;
- ... Ahn, Hee Kyung ;
- 외 15명
- 2026-02
- Oncology Research and Treatment
- KARGER
2022
Article
Acalabrutinib vs Rituximab Plus Idelalisib or Bendamustine in Relapsed/Refractory Chronic Lymphocytic Leukemia: ASCEND Results at similar to 4 Years of Follow-up
- Welslau, Manfred ;
- Jurczak, Wojciech ;
- Pluta, Andrzej ;
- Wach, Malgorzata ;
- Lysak, Daniel ;
- ... Lee, Jae Hoon ;
- 외 13명
- 2022-11
- Oncology Research and Treatment
- KARGER
2020
Article
Acalabrutinib (Acala) vs Idelalisib plus Rituximab (IdR) or Bendamustine plus Rituximab (BR) in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): ASCEND final results
- Welslau, M. ;
- Ghia, P. ;
- Pluta, A. ;
- Wach, M. ;
- Lysak, D. ;
- ... Lee, J. H. ;
- 외 15명
- 2020-10
- Oncology Research and Treatment
- KARGER
Article
Ascend Phase 3 Study of Acalabrutinib vs Investigator's Choice of Rituximab Plus Idelalisib (IDR) or Bendamustine (BR) in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)
- Hebart, Holger ;
- Ghia, Paolo ;
- Jurczak, Wojciech ;
- Pluta, Andrzej ;
- Wach, Malgorzata ;
- ... Lee, Jae Hoon ;
- 외 15명
- 2020-02
- Oncology Research and Treatment
- KARGER